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We have hydrodistilled the essential oil (EO) from the aerial parts of the Bhutanese medicinal plant, Pleurospermum amabile using a Clevenger apparatus and 
evaluated this EO by GC/GC-MS and NMR analysis followed by testing for bioactivity. The GC-MS analysis identified 52 compounds with (E)-isomyristicin 
as a major component (32.2%). Repeated purification yielded four compounds; (E)-isomyristicin (1), (E)-isoapiol (2), methyl eugenol (3) and (E)-isoelemicin 
(4). Compound 2 and the mother EO showed the best antiplasmodial activity against the Plasmodium falciparum strains, TM4/8.2 (chloroquine and antifolate 
sensitive) and K1CB1 (multidrug resistant). They exhibited mild antibacterial activity against Bacillus subtilis. None of the test samples showed cytotoxicity.  
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Essential oils (EOs) are secondary metabolites of aromatic plants 
with strong odors and volatile constituents composed of terpenoids 
(mono-, sesqui- and di-terpenes), alcohols, ketones, aldehydes, 
alkanes, and phenylpropanoids. They are responsible for the 
protection of plants against microbes, insects, and herbivores [1]. 
Since antiquity, mankind has used EOs and the EO-containing 
plants as medicinals (ethnomedicine), perfumeries, incense, 
fragrances and embalmments and in culinary and the preservation 
of foods [2].  
 
While many plants from various genera have been studied and some 
even commercially explored for EOs, the genus Pleurospermum 
(family Apiaceae) has been rarely investigated. Out of 30-50 
species of Pleurospermum reported from eastern Europe, north Asia 
and the Himalayan region [3], only five species; P. lindleyanum [4], 
P. austriacum [5], P. hookeri [6], P. wrightianum [7], and P. 
giraldii  [8] have been investigated for EOs. From the EO of P. 
lindleyani, 73 compounds were identified with 1-propoxy-2-
propanol, myristicine, cis-asarone, n-hexane, apiol, dimethyl ether, 
acetic acid, ethyl ester, spathulenol, 4-trimethylbenzene methanol, 
(E)-methyl isoeugenol and β-phellandrene as the main constituents 
[4]. Apparently, 1-propoxy-2-propanol, dimethyl ether, and n-
hexane appear to be solvent contaminant or the artifacts. From the 
EO of P. austriacum, 205 compounds were identified with 
germacrene D, β-caryophyllene, β-farnesene, β-phellandrene, δ-
cadinene, epi-cubebol, bicyclogermacrene, humulene, α-cadinol and 
hexadecanoic acid as some of the major components [5]. Out of 72 
GC peaks detected, 51 compounds were identified from the EO of 
P. hookeri and the major ones were palmitic acid, decanoic acid, 
ligustilide, piperitenal, (Z)-2-decenaldehyde and 2,4,5-trimethyl 
benzaldehyde [6]. From the EO of P. wrightianum, about 49 
compounds were identified with (E)-9-octadecenoic acid and 
1,3,5,7-cyclooctatetraene as the major parts of oil [7]. Out of 45 
compounds identified from the EO of P. giraldii, L-carvone and 
limonene were found to be the major components [8].  
In this study, we have analyzed a Bhutanese Himalayan medicinal 
plant, P. amabile (synonym Hymenidium amabile) for its essential 
oil (EO) components and biological activities for the first time. The 
aerial components of this plant are used in Bhutanese traditional 
medicine (BTM) for treating dyspepsia, poisoning (antidote) and 
fever (febrifuge) that correlates to the symptoms of microbial 
infections and malaria [9]. The hydrodistillation of the dried 
powdered aerial plant material (250 g dry weight) yielded 0.7 % 
EO. Fifty two component peaks were detected and identified by 
GC/GC-MS analysis including MS library matching and Kovats 
retention indices (KI) comparison techniques (Table 1).  
 
The percent contents of the EO were determined on the basis of 
their FID responses upon GC (Figure 1). (E)-isomyristicin (1) was 
the major component (32.5%) of the EO (Figure 1, Table 1) 
followed by limonene (17.0%), (E)-isoapiol (7.6%), β-
sesquiphellandrene (3.9%), methyl eugenol (3.8%), geranyl 
pentanoate (2.4%), (Z)-isomyristicin (2.3%), myrcene (2.3%), β-
caryophyllene (2.2%), geraniol (1.6%), (E)-isoelemicin (1.3%), 
geranyl isobutyrate (1.3%), myristicin (1.3%), valeranone (1.2%), 
β-citronellol (1.2%), β-selinene (1.2%), myrtenyl acetate (1.1%) and 
citronellyl acetate (1%).  
 
Although slightly different column and protocol conditions were 
used in the EOs analysis, many EO compounds of P. amabile 
including limonene, β-caryophyllene, germacrene D, α-cadinol, α-
bisabolene, α-pinene, myrcene, α-phellandrene, β-selinene, geranyl 
acetate, β-ocimene,  and few others (see Table 1 and literature for 
details) were found common to the EO of P. austriacum [5].  
 
Subsequent purification of the EO of P. amabile using column 
chromatography and preparative TLC plates resulted in the isolation 
of four compounds which were identified by KI and NMR 
spectroscopy data analysis as (E)-isomyristicin (1) [10-11], (E)-
isoapiol (2) [12], methyl eugenol (3) [13-14], and (E)-isoelemicin 
(4) [15] (Figure 1).  
Table 1: Chemical compositions of EO from P. amabile. 
GC Peak No. % oil Compound name KI
1 0.7 α-Pinene 934a
2 0.3 β-Pinene 977a
3 2.3 Myrcene 991a
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4 0.4 α-Phellandrene 1005a
5 0.2 Isoamyl isobutyrate 1013b
6 17.0 Limonene 1030a
7 0.5  (Z)-β-Ocimene  1038a
8 0.6 (E)-β-Ocimene 1048c
9 0.6 Terpinolene 1090c
10 0.6 Linalool 1100c
11 0.4 Isoamyl valerate  1106a
12 0.2 2-Methylbutyl isovalerate 1109c
13 0.2 Fenchol 1115a
14 0.2 Valeric acid, 3-methylbut-2-enyl-ester 1149b
15 0.2 Terpinen-4-ol   1179a
16 0.2 α-Terpineol 1189a
17 0.8 Myrtenol 1193a
18 0.6 Fenchyl acetate 1223c
19 1.2 β-Citronellol 1229a
20 0.2 2,4-Dimethoxytolouene 1240b
21 1.6 Geraniol 1256a
22 0.6 Citronellyl formate 1276a
23 0.3 Pinocarvyl acetate 1293a
24 1.1 Myrtenyl acetate  1329b
25 1.0 Citronellyl acetate 1354a
26 0.5 Geranyl acetate 1384c
27 0.2 2-methyl-5,7-dimethylene-1,8-nonadiene 1388b
28 0.2 Benzyl 2-methylbutanoate  1396b
29 3.8 Methyl eugenol  1406d
30 2.2 β-Caryophyllene 1427c
31 0.8 Aromadendrene 1462a
32 0.3 Geranyl n-propionate  1475a
33 0.2 Citronellyl isobutyrate   1484a
34 0.3 Germacrene D 1489a
35 1.2 β-Selinene 1500c
36 0.5 α-Bisabolene 1507a
37 1.3 Geranyl isobutyrate  1514a
38 1.3 Myristicin 1526a
39 3.9 β-Sesquiphellandrene 1529b
40 2.3 (Z)-Isomyristicin 1575e
41 0.2 Germacrene D-4-ol   1584a
42 0.7 Caryophyllene oxide 1587a
43 0.7 Geranyl isovalerate 1605b
44 2.4 Geranyl pentanoate 1611c
45 32.5 (E)-Isomyristicin 1624f
46 1.4 Dillapiole  1630i
47 0.3 α-Cadinol   1640a
48 1.3 (E)-Isoelemicin 1654g
49 0.5 Apiole  1665i
50 1.2 Valeranone 1684a
51 7.6 (E)-Isoapiol 1722h
52 0.2 Hexadecanal  1840c
* Retention time of the compounds based on GC-FID peaks (see Figure 1) and the  
  isolated compounds were highlighted in bold face. 
a Identified by NIST and NISTREP mass spectra library and agrees with [16]. 
b Identified tentatively by NIST and NISTREP mass spectra library. 
c Identified by NIST and NISTREP mass spectra library and agrees with [5].  
d Identified by its KI, 1H and 13C-NMR spectra comparisons with literature [13-14]. 
e Identified by NIST and NISTREP mass spectra library and agrees with [10]. 
f Identified by NIST and NISTREP mass spectra library and [10] and the comparison of  
 its NMR spectra with [11]. 
g Identified by 1H and 13C-NMR spectra comparison with [15]. 
h Identified by 1H and 13C-NMR spectra comparison with [12]. 
I Identified by comparing the calculated KI with [17].  
 
 
Given the traditional use of P. amabile to treat fever and various 
disorders bearing relevance to microbial infections and a malaria 
and the evidence that its CH2Cl2 and CHCl3 extracts exhibited 
significant antibacterial and antiplasmodial activity (Table 2) [9], 
we investigated the mother EO and three major compounds (1, 2 
and 4) isolated above for their antimicrobial, antimalarial and 
cytotoxicity activities (Table 2). The mother EO and compounds 1 
and 2 showed moderate antibacterial activity against B. subtilis with 
minimum inhibition zones (MIZ) ranging from 5-6 mm (Table 2). 
However, unlike the CH2Cl2 and CHCl3 extracts (from previous 
study, Table 2), the EO and its compounds (1, 2 and 4) did not show 
any activity against MRSA and other microbial strains tested here. 
The mother EO also exhibited moderate in vitro antiplasmodial 
activity against the P. falciparum strains: TM4/8.2 (a wild type 
chloroquine and antifolate sensitive strain) and K1CB1 (multidrug 
resistant strain) with IC50 values of 79.0 µg/mL and 72.3 µg/mL, 
respectively. These activities were lower than those exhibited by the 
CH2Cl2 and CHCl3 extracts (Table 2). Such correlations, including 
the antimicrobial activities, suggested that the more potent chemical 
components are present in the CH2Cl2 and CHCl3 extracts rather 
than in EO. In comparison to the antiplasmodial activity of the 
mother EO, compound 2 showed improved activity with IC50 values 
of 52.9 µg/mL and 69.9 µg/mL against TM4/8.2 and K1CB1, 
respectively. Compounds 1 did not show any antiplasmodial 
activity and compound 4 had poor solubility which restricted the 
determination of its accurate IC50 values for its highest test 
concentrations at 20 µg/mL. None of the test samples in this study 
showed any major cytotoxicity which thereby supports the 
assumption that the use of P. amabile in BTM is safe.  
 
 
Table 2: Antibacterial, antimalarial and cytotoxicity activities of EO and 
compounds 1, 2 and 4 isolated from P. amabile.  
 
 
NT: Not Tested, NA: Not Active. 
a Original activity taken from [9]. 
b Positive controls for antibacterial activity. 
c Positive controls for antiplasmodial activity. 
d Positive controls for cytotoxicity activity. 
 
 
In conclusion, this study found that P. amabile, which is one of the 
important medicinal ingredients of the Bhutanese traditional 
medicine, has EO (0.7% oil w/w) with (E)-isomyristicin (32.5% oil) 
as the major component. The EO and compounds 1 and 2 inhibited 
the growth of only B. subtilis and no other strains. The EO and 
compound 2 also demonstrated moderate in vitro antiplasmodial 
activity without mammalian cell toxicity. This in vitro bioactivity of 
the EO supports the reported biological activities [9] of the crude 
extracts of the plant which further verifies the safety record of P. 
amabile used in BTM for treating various aforementioned disorders. 
However, in vivo experiments will be required to further justify the 
use of EO for treating humans. 
 
Experimental 
Plant material and essential oil: P. amabile is an endangered 
species inhabiting the open scrub, alpine turf and the semi-stable 
screes of high altitude Himalayan mountains (3950 to 4700 meters 
above sea level) in Bhutan [18-19]. It grows to 15-50 cm tall with 
stout root, solitary stem, sheathed broad leaves, white to dark purple 
flower and ovoid-oblong fruit [3,18]. For this study, the aerial 
components of P. amabile were collected from Lingzhi (Altitude: 
4200 m) in Thimphu district in July 2009. A herbarium specimen 
(voucher number 29) was deposited at the herbarium of the 
Manjong Sorig Pharmaceuticals, Ministry of Health, Thimphu, 
Bhutan. The air-dried plant material (250 g) was powdered and 
hydro-distilled using a Clevenger apparatus for 3 hours to obtain the 
pale green pleasantly aromatic EO (1.8 mL). The EO collected was 
dried over MgSO4. The EO was stored at 0–5°C until analysed.  
Samples  
Antibacterial 
(MIZ in mm) 
   Antiplasmodial 
(IC50 in μg/mL)    
     Cytotoxicity
(IC50 in μg/mL)
B. subtilis MRSA TM4/8.2 K1CB1 Vero KB 
CH2Cl2 extract 14
a      12a 12.1±0.4a 10.9±2.3a >25a >25a
CHCl3 extract 6
a NT 7.8±1.8a 7.3±2.6a >25a >25a
Essential oil (EO) 5 NA 79.0±4.6 72.3±2.1 >100 >100
(E)-Isomyristicin (1) 5 NA >100 >100 >100 >100
(E)-Isoapiol (2) 6 NA 52.9± 2.9 69.9±2.0 >100  >100
(E)-Isoelemicin (4) NA   NA >20 >20 >20 >20
Amoxicillinb       8   
Vancomycinb    13.5    
Chloroquinec   0.010 0.089   
Cycloguanilc   0.009 0.810   
Pyrimethaminec   0.020 7.700   
Ellipticined    0.093  
Doxorubicind                  0.56 





Analysis of EO using GC and GC-MS: The EO was analysed for its 
chemical composition using GC and GC-MS systems and 
equipment as described by us previously [20]. The GC analysis was 
performed on a Shimadzu GC-2010 Plus gas chromatograph. 
Hydrogen was used as carrier gas and the separation was achieved 
using a Restek fused silica capillary column (Rxi-5MS: 30 m × 0.25 
mm i.d., 0.25 μm film thickness). Injector and detector temperature 
were set at 260 °C and 300 °C, respectively. The starting oven 
temperature was programmed at 40 °C with an increasing 
temperature of 6 °C/min until it reached 290 °C. KI were obtained 
by GC-FID analysis of an aliquot of the EOs spiked with a 
commercially available n-alkane mixture (C9 to C21). The GC-MS 
analysis was performed using Shimadzu QP5050A GC-MS system 
(electron impact (EI) mode at 70 eV). The column and the GC-MS 
chromatographic conditions were same as that for GC with the 
exception that the He was used as carrier gas. The EO constituents 
were identified by comparing mass spectra with NIST and 
NISTREP mass spectra library of GC-MS data system and further 
confirmed by comparing their KI with those reported [5,10,16-17].  
 
Isolation of compounds from EO: The equipment, general protocols 
and isolation techniques were carried out as described by us 
previously [21]. The known compounds were identified through MS 
library matching techniques (NIST and NISTREP mass spectra 
library) and then confirmed through comparison of their MS and 
NMR spectra (500 MHz, CDCl3) with those reported (see footnote 
of Table 1 for references).  
 
The EO (383 mg) was column chromatographed on a silica gel (120 
g, 200-300 mesh) eluting with a gradient solvent system of CHCl3-
petroleum spirit (v/v ratio of 0:100, 5:95, 10:90, 15:85, 20:80, 
30:70, 50:50, 70:30, 100:0) to obtain nine fractions, PAoil.1-9. 
Further separation of PAoil.1 using reversed phase preparative silica 
gel plates in highly polar solvent system (10% H2O:90% MeOH) 
yielded compound 1 (185.3 mg) (major constituent of oil, Fig. 1) 
which was identified as (E)-isomyristicin through NMR spectral 
data analysis. Eluting fraction PAoil.5 with isocratic or fixed ratio 
solvent system (10% petroleum spirit:90% CHCl3) on a normal 
phase silica gel column furnished (E)-isoapiol (2) (30.7 mg, Fig. 1) 
and methyl eugenol (3) (44.7 mg, Fig. 1). Separation of fraction 
PAoil.8 on a preparative silica plate using the solvent system of 
30% diethyl ether:96% petroleum spirit, yielded (E)-isoelemicin (4) 
(3.4 mg, Figure 1).  
 
Bioassay methods: Antimicrobial, antiplasmodial and cytotoxicity 
bioassays were carried out using the standard protocols reported by 
us previously [9]. The test strains of Plasmodium falciparum used 
for the antiplasmodial bioassay were K1CB1, a multidrug resistant 
strain; and TM4/8.2, a wild type chloroquine and antifolate sensitive 
strain. Chloroquine (Sigma-Aldrich), cycloguanil (Sigma-Aldrich) 
and pyrimethamine (Sigma-Aldrich) were used as positive controls 
in the antiplasmodial assays. For the antimicrobial assay, the test 
organisms including Escherichia coli (ATCC 25922), Bacillus 
subtilis (ATCC 6633), Staphylococcus aureus (ATCC 6538), 
methicillin resistant S. aureus (MRSA), (DMST 20651), S. 
epidermidis (ATCC 12228), Vibrio cholerae (DMST 2873) and 
Candida albicans (ATCC 10231) were used. Amphotericin B 
(Sigma-Aldrich, USA) was used as a positive control for antifungal 
testing against Candida albicans (not shown in Table 2 as the 
samples were found to be inactive). Vancomycin (Edicin, Slovenia) 
and amoxicillin (GPO, Thailand) were used as the positive controls 
for antibacterial assays. For the cytotoxicity assay, normal vero cells 
from kidney of African green monkey, Cecopithecus aethiops and 
the human oral carcinoma KB cells were used. Ellipticine (Sigma-
Aldrich, USA) and doxorubicin (Sigma-Aldrich, USA) were used as 
reference drugs for cytotoxicity activities. All the experiments were 
performed three times in duplicate (3x2) and DMSO (0.1%) and 
distilled water were used as controls to rule out the solvent effects 
on the bioassay results of the test samples.  
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